These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28747519)

  • 21. Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis.
    Hinojosa-Gonzalez DE; Nolazco JI; Saffati G; Kronstedt S; Jones JA; Kadmon D; Badal J; Slawin JR
    Eur Urol Focus; 2024 Mar; 10(2):234-241. PubMed ID: 38242825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
    Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
    Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
    Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE
    Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis.
    Hatzichristodoulou G; Wagenpfeil S; Wagenpfeil G; Maurer T; Horn T; Herkommer K; Hegemann M; Gschwend JE; Kübler H
    World J Urol; 2016 Jun; 34(6):811-20. PubMed ID: 26420596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.
    Morizane S; Honda M; Shimizu R; Tsounapi P; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2022 Apr; 27(4):781-789. PubMed ID: 35076818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
    Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
    World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
    Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
    BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performed.
    Ramírez-Backhaus M; Mir Maresma MC; Mascarós JM; Bertolo R; Hernández J; Gómez Ferrer A; Casanova-Ramón Borja J; Domínguez Escrig JL; Collado-Serra A; Calatrava Fons A; Rubio-Briones J
    Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):480-487. PubMed ID: 31174878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
    Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
    Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.
    Oishi T; Hatakeyama S; Tabata R; Fujimori D; Fukuda M; Shinozaki T; Ishii N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Sato S; Ohyama C
    Sci Rep; 2023 Mar; 13(1):3436. PubMed ID: 36859718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
    Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data.
    Rousseau C; Rousseau T; Mathieu C; Lacoste J; Potiron E; Aillet G; Nevoux P; Le Coguic G; Campion L; Kraeber-Bodéré F
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1849-56. PubMed ID: 27164901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
    Matsumoto T; Hatakeyama S; Ookubo T; Mitsuzuka K; Narita S; Inoue T; Yamashita S; Narita T; Koie T; Kawamura S; Tochigi T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
    Med Oncol; 2017 Oct; 34(12):190. PubMed ID: 29090390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.
    KleinJan GH; van den Berg NS; de Jong J; Wit EM; Thygessen H; Vegt E; van der Poel HG; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1278-87. PubMed ID: 26768422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.
    Dell'Oglio P; Abdollah F; Suardi N; Gallina A; Cucchiara V; Vizziello D; Zaffuto E; Cantiello F; Damiano R; Shariat S; Montorsi F; Briganti A
    J Endourol; 2014 Apr; 28(4):416-23. PubMed ID: 24188052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
    Lughezzani G; Lazzeri M; Buffi NM; Abrate A; Mistretta FA; Hurle R; Pasini L; Castaldo L; Zandegiacomo De Zorzi S; Peschechera R; Fiorini G; Taverna G; Casale P; Guazzoni G
    Urol Oncol; 2015 Aug; 33(8):337.e7-14. PubMed ID: 26055430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan.
    Morizane S; Honda M; Fukasawa S; Komaru A; Inokuchi J; Eto M; Shimbo M; Hattori K; Kawano Y; Takenaka A
    Int J Clin Oncol; 2018 Jun; 23(3):568-575. PubMed ID: 29230586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.